loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Soticlestat

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Soticlestat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ovid Therapeutics Reports Q2 2024 Results And Business Updates
    Ovid Therapeutics Reports Q2 2024 Results And Business Updates

    13 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/13/2929123/0/en/Ovid-Therapeutics-Reports-Business-Updates-and-Second-Quarter-2024-Financial-Results.html

    GLOBENEWSWIRE
    13 Aug 2024
    Share Share
    Ovid Reports On Takeda’s Phase 3 Topline Results For Soticlestat
    Ovid Reports On Takeda’s Phase 3 Topline Results For Soticlestat

    17 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/17/2899490/0/en/Ovid-Therapeutics-Reports-on-Takeda-s-Announcement-of-Phase-3-Topline-Study-Results-for-Soticlestat.html

    GLOBENEWSWIRE
    17 Jun 2024
    Share Share
    Takeda Announces Phase 3 Results For Soticlestat In Lennox-Gastaut Syndrome
    Takeda Announces Phase 3 Results For Soticlestat In Lennox-Gastaut Syndrome

    17 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240617592767/en

    BUSINESSWIRE
    17 Jun 2024
    Share Share
    Epilepsy fail hands late-stage pipeline blow to Takeda
    Epilepsy fail hands late-stage pipeline blow to Takeda

    17 Jun 2024

    // Phil Taylor PHARMAPHORUM

    https://pharmaphorum.com/news/epilepsy-fail-hands-late-stage-pipeline-blow-takeda

    Phil Taylor PHARMAPHORUM
    17 Jun 2024
    Share Share
    Takeda takes full control of drug for rare epilepsies
    Takeda takes full control of drug for rare epilepsies

    04 Mar 2021

    // Jacob Bell BIOPAHRAMADIVE

    https://www.biopharmadive.com/news/takeda-ovid-soticlestat-rare-epilepsy-drug/595913/

    Jacob Bell BIOPAHRAMADIVE
    04 Mar 2021
    Share Share
    Takeda, Ovid Therapeutics announce phase 2 ELEKTRA study of soticlestat
    Takeda, Ovid Therapeutics announce phase 2 ELEKTRA study of soticlestat

    27 Aug 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=130667&sid=2

    PHARMABIZ
    27 Aug 2020
    Share Share